Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Src homology-2 phosphatases are a family of protein tyrosine phosphatases (PTPs) characterized by the presence of one or more Src homology 2 (SH2) domains. The most studied members are SHP-1 and SHP-2, which play critical roles in cell signaling by modulating processes such as progenitor cell development, cellular growth, tissue inflammation, and chemotaxis. SHP2 contains two tandem N-terminal SH2 domains (N-SH2 and C-SH2), followed by a single catalytic PTP domain. Under basal conditions, the N-SH2 domain blocks the active site of the PTP domain, maintaining an auto-inhibited state. Binding to phosphotyrosine-containing motifs relieves this inhibition and activates the enzyme. Activating mutations in PTPN11/SHP2 are associated with various cancers and germline mutations cause developmental syndromes such as Noonan syndrome.
Allosteric inhibition (e.g., SHP099), Active site inhibition (e.g., CNBCA)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Src Homology-2 Phosphatase (SHP).